Доксиламин и мелатонин в коррекции нарушений сна в гинекологической практике

Авторы:
  • Д. И. Бурчаков
    ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России, Москва, Россия
Журнал: Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2018;118(4): 67-72
Просмотрено: 2689 Скачано: 961
В статье представлен обзор литературы, посвященной инсомнии, развивающейся на фоне гинекологических расстройств: нарушений, ассоциированных с менструальным циклом; эндометриоза и симптомов, возникающих в пери- и постменопаузе. Описаны методы лечения, в том числе отечественными безрецептурными препаратами доксиламина и мелатонина.
Ключевые слова:
  • сон
  • дисменорея
  • перименопауза
  • доксиламин
  • мелатонин

КАК ЦИТИРОВАТЬ:

Бурчаков Д.И. Доксиламин и мелатонин в коррекции нарушений сна в гинекологической практике. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2018;118(4):67-72. https://doi.org/10.17116/jnevro20181184267

Список литературы:

  1. ACOG Committee on Adolescent Health Care ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol. 2006;108:1323-1328.
  2. Mallampalli MP, Carter CL. Exploring sex and gender differences in sleep health: a Society for Women’s Health Research Report. J Womens Health. 2014;23:553-562. https://doi.org/10.1089/jwh.2014.4816
  3. Shepertycky MR, Banno K, Kryger M. H. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep. 2005;28:309-314.
  4. Bakhshani NM, Mousavi MN, Khodabandeh G. Prevalence and severity of premenstrual symptoms among Iranian female university students. J Pak Med Assoc. 2009;59:205-208.
  5. Silva CML, Gigante DP, Carret MLV, Fassa AG. Population study of premenstrual syndrome. Rev Saude Publica. 2006;40:47-56. https://doi.org/10.S0034-89102006000100009.
  6. Wittchen H-U, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32:119-132.
  7. Baker FC, Sassoon SA, Kahan T, Palaniappan L, Nicholas CL, Trinder J, Colrain IM. Perceived poor sleep quality in the absence of polysomnographic sleep disturbance in women with severe premenstrual syndrome. J Sleep Res. 2012;21:535-545. https://doi.org/10.1111/j.1365-2869.2012.01007.x
  8. Gupta R, Lahan V, Bansal S. Subjective sleep problems in young women suffering from premenstrual dysphoric disorder. N Am J Med Sci. 2012;4: 593-595. https://doi.org/10.4103/1947-2714.103326
  9. Lundström V, Eneroth P, Swahn ML. Diurnal variation of uterine contractility. Br J Obstet Gynaecol. 1984;91:155-159.
  10. Chiu M-H, Wang H-H, Hsu S-C, Liu I-P. Dysmenorrhoea and self-care behaviours among hospital nurses: a questionnaire survey. J Clin Nurs. 2013;22:3130-3140. https://doi.org/10.1111/jocn.12240
  11. Attarchi M, Darkhi H, Khodarahmian M, Dolati M, Kashanian M, Ghaffari M, Mirzamohammadi E, Mohammadi S. Characteristics of menstrual cycle in shift workers. Glob J Health Sci. 2013;5:163-172. https://doi.org/10.5539/gjhs.v5n3p163
  12. Baker FC, Driver HS, Rogers GG, Paiker J, Mitchell D. High nocturnal body temperatures and disturbed sleep in women with primary dysmenorrhea. Am J Physiol. 1999;277:1013-1021.
  13. Bahrami A, Sadeghnia H, Avan A, Mirmousavi SJ, Moslem A, Eslami S, Heshmati M, Bahrami-Taghanaki H, Ferns GA, Ghayour-Mobarhan M. Neuropsychological function in relation to dysmenorrhea in adolescents. Eur J Obstet Gynecol Reprod Biol. 2017;215:224-229. https://doi.org/10.1016/j.ejogrb.2017.06.030
  14. Marjoribanks J, Proctor M, Farquhar C, Derks RS. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2010;CD001751. https://doi.org/10.1002/14651858.CD001751.pub2
  15. Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, Raine-Fenning N. The social and psychological impact of endometriosis on women’s lives: A critical narrative review. Hum Reprod Update. 2013;19:625-639. https://doi.org/10.1093/humupd/dmt027
  16. Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women’s lives: a qualitative study. BMC Womens Health. 2014;14:123. https://doi.org/10.1186/1472-6874-14-123
  17. Nunes FR, Ferreira JM, Bahamondes L. Pain threshold and sleep quality in women with endometriosis. Eur J Pain. 2015;19:15-20. https://doi.org/10.1002/ejp.514
  18. Ярмолинская М.И., Зайцев Д.В., Тхазaплижева С.Ш. Мелатонин и генитальный эндометриоз — новые возможности терапии. Журнал акушерства и женских болезней. 2015;44:67-75.
  19. Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstet. Gynecol. Clin North Am. 2011;38:567-586. https://doi.org/10.1016/j.ogc.2011.06.002
  20. Simpson L, McArdle N, Eastwood PR, Ward KL, Cooper MN, Wilson AC, Hillman DR, Palmer LJ, Mukherjee S. Physical Inactivity Is Associated with Moderate-Severe Obstructive Sleep Apnea. J Clin Sleep Med. 2015;11:1091-1099. https://doi.org/10.5664/jcsm.5078
  21. Mirer AG, Peppard PE, Palta M, Benca RM, Rasmuson A, Young T. Menopausal hormone therapy and sleep-disordered breathing: evidence for a healthy user bias. Ann Epidemiol. 2015;25:779-784. https://doi.org/10.1016/j.annepidem.2015.07.004
  22. Cintron D, Lipford M, Larrea-Mantilla L, Spencer-Bonilla G, Lloyd R, Gionfriddo MR, Gunjal S, Farrell AM, Miller VM, Murad M.H. Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis. Endocrine. 2017;55:702-711. https://doi.org/10.1007/s12020-016-1072-9
  23. Birkhäuser MH, Panay N, Archer DF, Barlow D, Burger H, Gambacciani M, Goldstein S, Pinkerton JA, Sturdee DW. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric. 2008;11:108-123. https://doi.org/10.1080/13697130801983921
  24. Baber RJ, Panay N, Fenton A; IMS Writing Group 2016 IMS. Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19:109-150. https://doi.org/10.3109/13697137.2015.1129166
  25. Мадаева И.М., Семенова Н.В., Данусевич И.Н., Колесникова Л.И. Климактерический синдром, расстройства сна и мелатонин. Эффективная фармакотерапия. 2016;19:86-92.
  26. Jehan S, Jean-Louis G, Zizi F, Auguste E, Pandi-Perumal SR, Gupta R, Attarian H, McFarlane SI, Hardeland R, Brzezinski A. Sleep, Melatonin, and the Menopausal Transition: What Are the Links? Sleep Sci. 2017;10:11-18. https://doi.org/10.5935/1984-0063.20170003
  27. Bellipanni G, Bianchi P, Pierpaoli W, Bulian D, Ilyia E. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp Gerontol. 2001;36:297-310.
  28. Кузнецова И.В., Бурчаков Д.И. Возможности терапии климактерических симптомов с помощью препаратов мелатонина. Гинекология. 2015;17:44-48.
  29. Chojnacki C, Walecka-Kapica E, Klupinska G, Pawlowicz M, Blonska A, Chojnacki J. Effects of fluoxetine and melatonin on mood, sleep quality and body mass index in postmenopausal women. J Physiol Pharmacol. 2015;66:665-671.
  30. Amstrup AK, Sikjaer T, Pedersen SB, Heickendorff L, Mosekilde L, Rejnmark L. Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial. Clin Endocrinol. 2016;84:342-347. https://doi.org/10.1111/cen.12942
  31. Стрыгин К.Н., Полуэктов М.Г. Инсомния. Медицинский совет. 2017;1:52-58.
  32. Rudolph LM, Bentley GE, Calandra RS, Paredes AH, Tesone M, Wu TJ, Micevych PE. Peripheral and Central Mechanisms Involved in the Hormonal Control of Male and Female Reproduction. J Neuroendocrinol. 2016;28:1-12. https://doi.org/10.1111/jne.12405
  33. Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr J. 2015;14:102. https://doi.org/10.1186/s12937-015-0093-1